Original Source(s)
Related Content
IL-17, IL-23 Therapies Lead Psoriasis Care
Network meta-analysis suggests higher PASI 90 response rates with biologics vs oral systemic therapies
April 12, 2026
-
3 min
Oral TYK2 Inhibition in Atopic Dermatitis
Phase 2 trial evaluated once-daily oral TYK2 inhibition in adults with moderate to severe AD.
February 5, 2026
-
4 min